UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):                  June 28, 2012
Hydromer, Inc. (Exact name of registrant as specified in its chapter)
New Jersey (State or other jurisdiction of incorporation)	001-31238 (Commission File Number)	22-2303576 (IRS Employer Identification No.)

35 Industrial Parkway Branchburg, N.J.
(Address of principal executive offices) 08876
(Zip Code)

Registrant's telephone number, including area code:                (908) 722 – 5000  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c))

Item 8.01 Other Events

Press Release Announcing Hydromer, Inc. Entering Into a Strategic Development Agreement with N8 Medical Inc. for a new class of antimicrobial coatings

EXHIBIT INDEX

Exhibit No.	Description of Exhibit
99.46	Press Release issued June 28, 2012

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	_______Hydromer, Inc._______ Registrant _______/s/ Robert Y. Lee_______
Date __ June 28, 2012____	Robert Y. Lee Chief Financial Officer